Etude Resume (Retraitement Sunitinib Rein Metastatique)

Trial Profile

Etude Resume (Retraitement Sunitinib Rein Metastatique)

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 May 2016

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Acronyms ETUDE RESUME
  • Sponsors Pfizer
  • Most Recent Events

    • 15 May 2016 Results (n=52) published in the European Journal of Cancer
    • 15 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top